To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.

Inclusion Criteria:

• Male subjects of ≥ 18 years of age.
• Primary diagnosis of Benign Prostate Hypertrophy (BPH).
• Candidate for Rezūm therapy as per clinical decision of Investigator.
• Willing and able to accurately complete the required questionnaires.
• Willing and able to provide signed and dated informed consent

Exclusion Criteria:

• Characteristics indicating a poor compliance with study protocol requirements.
• Disease or other health condition that is not suitable for this study.
• Unable or unwilling to provide signed informed consent.

self-representation

• Male subjects of ≥ 18 years of age.
• Primary diagnosis of Benign Prostate Hypertrophy (BPH).
• Candidate for or have already completed Rezūm therapy as per clinical decision of Investigator.